Kornitzer Capital Management’s Core Laboratories CLB Stock Holding History

Kornitzer Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Sell	24,085 -690	-3%	-$9.85K	0.01%	530
2026 Q1	$416K	Sell	24,775 -2,200	-8%	-$39.4K	0.01%	473
2025 Q4	$432K	Sell	26,975 -4,175	-13%	-$62.1K	0.01%	475
2025 Q3	$385K	Sell	31,150 -3,860	-11%	-$45.3K	0.01%	474
2025 Q2	$403K	Sell	35,010 -505	-1%	-$5.99K	0.01%	459
2025 Q1	$532K	Hold	35,515	–	–	0.01%	420
2024 Q4	$615K	Buy	+35,515	New	+$685K	0.01%	415
2020 Q1	–	Sell	-68,105	Closed	-$2.57M	–	498
2019 Q4	$2.57M	Sell	68,105 -2,385	-3%	-$107K	0.05%	314
2019 Q3	$3.29M	Buy	+70,490	New	+$3.28M	0.06%	291
2014 Q4	–	Sell	-1,500	Closed	-$220K	–	432
2014 Q3	$220K	Hold	1,500	–	–	﹤0.01%	407
2014 Q2	$251K	Buy	+1,500	New	+$267K	﹤0.01%	393

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Kornitzer Capital Management's CLB Position: Q2 2026 in Review

Kornitzer Capital Management reduced its Core Laboratories (CLB) stake by 2.8% in Q2 2026, selling an estimated $9.85K and leaving 24,085 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #530.

Kornitzer Capital Management first reported a position in CLB in Q2 2014 and has held it in 11 quarters since. The position peaked at $3.29M in Q3 2019. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Kornitzer Capital Management held 24,085 shares of Core Laboratories worth $281K as of Q2 2026.
Kornitzer Capital Management sold 690 Core Laboratories shares in Q2 2026, an estimated $9.85K.
Core Laboratories made up 0.01% of Kornitzer Capital Management's portfolio in Q2 2026, its #530 holding.
Kornitzer Capital Management first reported a position in Core Laboratories in Q2 2014 and has held it in 11 quarters since.
Kornitzer Capital Management's Core Laboratories position peaked at $3.29M in Q3 2019.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.